Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000263916 is a human gene encoding a long non-coding RNA (lncRNA), referred to provisionally as “novel transcript, sense intronic to C18orf32.” It is annotated based on its location within the intronic region (in sense orientation) of the C18orf32 gene. This transcript belongs to the lncRNA class and, as of current knowledge, does not encode any protein products, has no associated molecular function, disease role, or known relevance as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Novel transcript, sense intronic to C18orf32 (ENSG00000263916).